HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank downgraded Lilly to Reduce ...

The indicator measures the total value of the US stock market against the country's gross domestic product, or GDP. In other ...

The developer behind transforming Pfizer’s former headquarters in Midtown Manhattan into about 1,600 apartments is hoping ...

An office tower in Chicago’s River North neighborhood is in financial limbo two years after its private-equity owner, ...

Feinson's survived two world wars, a flood and a fire in downtown Danbury. Ives Bank will honor the hometown store in the ...